Concerning this, it has been reported that FGFR2 is the most frequent somatic gene fusion in iCCA and a variety of its fusion partners has been detected, suggesting that this genetic event may be a suitable candidate both for therapeutic strategies and clinical management [90,140]. The gene discussed is FGFR2; the disease is infantile convulsions and choreoathetosis.